Efficacy and Safety Study of Oral Fludarabine Phosphate in Combination With Mitoxantrone as First Line Treatment in Follicular NHL

• Status: Completed
• Trial end date: 2006-10-01

Summary

The purpose of the study is to demonstrate that oral fludarabine phosphate is comparable to i.v. formulation used in combination with mitoxantrone in terms of efficacy, safety and risk/benefit profile

• Phase: Phase 2

Details

• Lead Sponsor: Genzyme, a Sanofi Company
• Treatments: Fludarabine; Fludarabine phosphate; Mitoxantrone; Vidarabine